Legal Representation
Attorney
Kumiko Ide
USPTO Deadlines
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 24, 2025 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Dec 24, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 24, 2025 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Dec 2, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 28, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 28, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 28, 2025 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Jun 5, 2025 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Jun 5, 2025 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Jun 5, 2025 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| May 7, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 7, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 7, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 23, 2024 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Nov 7, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Nov 7, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Oct 31, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Oct 30, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 28, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 30, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jul 30, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 25, 2024 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Mineral food supplements; food supplements; vitamin preparations; dietary fiber to aid digestion; nutritional supplements; dietary supplements for humans; nutraceutical preparations for therapeutic or medical purposes for the treatment of obesity, metabolic disorders, atopic dermatitis, hypersensitivity reaction, irritable bowel syndrome, gastrointestinal reflux disease, reflux esophagitis, and functional dyspepsia; probiotic supplements; antioxidant pills being food supplements; enzyme dietary supplements.
Additional Information
Design Mark
The mark consists of the wording "WILL" in stylized font below a set of Korean characters.
Other
The non-Latin characters in the mark transliterate to "WILL" and this has no meaning in a foreign language.
Classification
International Classes
005